Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
Twill by Dario to Offer a Benefit for AARP Members
08:30am, Tuesday, 15'th Oct 2024
New offer gives Dario access to millions of AARP members, enabling engagement with people over 50 in health and well-being beginning in January 2025 NEW YORK , Oct. 15, 2024 /PRNewswire/ -- DarioHealt
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
01:01pm, Wednesday, 02'nd Oct 2024
DarioHealth (DRIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Bet on 5 Top-Ranked Stocks With Rising P/E
05:30am, Wednesday, 02'nd Oct 2024
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Adverum Biotechnologies (ADVM), IceCure Medical (ICCM), DarioHealth (DRIO), Energous (WATT) and V
The new contract significantly expands Dario's footprint with more than a million eligible members beginning January 2025 NEW YORK , Oct. 1, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dar
Bet on 5 Top-Ranked Stocks With Rising P/E for Stellar Gains
07:05am, Wednesday, 18'th Sep 2024
Tap five stocks with increasing P/E ratios. These stocks include TAL Education Group (TAL), The RealReal (REAL), DarioHealth (DRIO), HealthEquity (HQY) and Energous (WATT).
DarioHealth And 2 Other Stocks Under $5 Executives Are Buying
05:49am, Friday, 13'th Sep 2024
The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
The integration of Twill's condition-specific, expert-led peer groups will enhance the member experience and deepen engagement with Dario's proven cardiometabolic solution NEW YORK , Sept. 12, 2024 /P
New Research Confirms the Benefit of Dario's Integrated, Data-Driven Approach to Health and Chronic Condition Management NEW YORK , Sept. 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Da
DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript
03:00pm, Saturday, 10'th Aug 2024
DarioHealth Corp. (NASDAQ:DRIO ) Q2 2024 Results Conference Call August 8, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven
DarioHealth Corp. (DRIO) Q2 Earnings Beat Estimates
08:46am, Thursday, 08'th Aug 2024
DarioHealth Corp. (DRIO) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.29 per share. This compares to loss of $0.58 per share a year ago.
DarioHealth Reports Second Quarter 2024 Financial and Operating Results
06:30am, Thursday, 08'th Aug 2024
Q2 revenue of $6.26 million reflects an increase of 8.6% over Q1 2024, and an increase of 1.7% over Q2 of 2023, driven primarily by increased B2B2C revenues Q2 commercial and consumer revenues totaled
DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th
08:30am, Tuesday, 30'th Jul 2024
Company to host conference call and webcast at 8:30am ET NEW YORK , July 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced
Dario Expands GLP-1 Solution Client Base with New Employer Contract
08:30am, Tuesday, 16'th Jul 2024
Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets NEW YORK , July 16, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario"
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
08:30am, Tuesday, 25'th Jun 2024
New research confirms behavior change driven by Dario digital platform is sustainable for 12 month period and supports clinical results for members taking a GLP-1 Additional research demonstrates 31%
3 Small-Cap AI Stocks to Buy Now: June 2024
06:00am, Tuesday, 25'th Jun 2024
While the innovation sphere constantly focuses on artificial intelligence these days, the top players in the field have gotten a lot of attention – maybe too much attention. Recently, we've seen the
